# ProKidney (PROK) — News

PROK · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prok/news

## Recent headlines

- [Applied Optoelectronics files to offer $600M shares](https://www.ainvest.com/news/applied-optoelectronics-files-offer-600m-shares-2605) — AInvest Wire, May 14, 2026
  Applied Optoelectronics Inc. (AAOI) has drawn attention amid recent market activity involving a $600 million trading volume tied to eBay (EBAY), though AAOI itself has not filed for a new share offering as of this writing. The company reported a net loss of $2.0 million for Q4 2025 , representing…
- Prokidney focused Co. resources on Proact 1 — AInvest Wire, Sep 3, 2024
  Prokidney focused Co. resources on Proact 1 Prokidney Corp. (PROK), a pioneering late-stage cellular therapeutics company specializing in chronic kidney disease (CKD), has recently announced updated positive interim data from its RMCL-002 Phase 2 study [1]. These encouraging results support the…
- ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering — AInvest Wire, Jun 10, 2024
  ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering ProKidney Corp. (PROK), a pioneering late-clinical-stage cellular therapeutics company, recently announced plans for a proposed public offering of Class A ordinary shares…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).